Salute e Benessere

Oxurion Announces Extraordinary General Shareholders' Meeting

Oxurion Announces Extraordinary General Shareholders' MeetingLeuven, BELGIUM – June 4, 2024 – 07:00 PM CET– Oxurion NV(Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, announces an extraordinary general shareholders' meeting to be held on Thursday July 4, 2024 at 11:00 AM (CET).This extraordinary general shareholders' meeting regards the proposal of share consolidation in respect of all outstanding shares of the Company by means of a 1-for-10,000...
Nasdaq GlobeNewswire
04/06/2024

VALNEVA - Declaration of shares and voting rights: May 31, 2024

VALNEVADeclaration of shares and voting rightsMay 31, 2024__________________________________________________________________________________________Company name: VALNEVA Registered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France) Regulated market of Euronext Paris - Compartment B Declaration date: June 4, 2024 Number of sharescomposing the share capital of ValnevaTotal number of voting rights including suspended voting rights* Description of the change ...
Nasdaq GlobeNewswire
04/06/2024

MGI Unveils New European Headquarters in Berlin, Germany

The new facility, conveniently located near the Berlin Brandenburg Airport and open to external visits, features MGI's latest products and technologies. The space spans over 600 square meters and features the company's very own Customer Experience Center (CEC) and advanced labs, with plans for further expansion. It will also be home to prototypes of upcoming MGI products for early access and testing by European partners and collaborators. The new facility, conveniently located near the Berlin...
PR Newswire
04/06/2024

Valneva to Present and Hold Investor Meetings at Upcoming Conferences in June

Saint-Herblain (France), June 4, 2024–Valneva SE(Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that management will participate at several upcoming investor conferences in the United States and Europe during June 2024. Valneva will present and meet with global institutional investors to discuss VLA15, the world's leading Lyme Disease vaccine candidate, in Phase 3 development and partnered with Pfizer; the Company's growing commercial business,...
Nasdaq GlobeNewswire
04/06/2024

Dr. María José Torres, Head of the Allergology Department of the HRU of Malaga…

EAACI focuses on planetary health as a key feature of the research agenda VALENCIA, Spain, June04, 2024(GLOBE NEWSWIRE) -- The Closing Ceremony of the EAACI Congress 2024, a meeting forum for experts in Allergy and Immunology from countries all over the world, has taken place. At the closing of the Congress,Dr. María José Torres, Professor of Medicine and Head of the Allergology Service of the Regional University Hospital of Malaga, takes the lead as thenew President of EAACI ;...
Nasdaq GlobeNewswire
04/06/2024

Esoteric Testing Market Worth $48.3 billion | MarketsandMarkets™

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=76794708 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=76794708 Browse in-depth TOC on "Esoteric Testing Market" 273 - Tables48 - Figures304 - Pages Esoteric Testing Market Scope: The oncology testing segment is projected to register the highest CAGR in the forecasted period for esoteric testing market, by type segment, in 2023...
PR Newswire
04/06/2024

RestoringVision Awarded $4 Million Grant to Restore Sight to 2.5 Million People…

The programs include the following: The programs include the following: India: RestoringVision will collaborate with Supreme Task India, an NGO focused on access to affordable healthcare, to provide 500,000 adults aged 35-65 working in visually intensive occupations in Odisha state – one of the poorest states inIndia- with vision screenings and reading glasses. These include tailors, weavers, mechanics, carpenters, and farmers among others, to enable them to see clearly and continue...
PR Newswire
04/06/2024

Tiziana Life Sciences Submits Grant Application to ALS Association to Fund…

Foralumab, a fully human anti-CD3 monoclonal antibody, is a biological drug candidate that has been shown to stimulate T regulatory cells when dosed intranasally. At present, 10 patients with Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS) have been dosed in an open-label intermediate sized Expanded Access (EA) Program with either an improvement or stability of disease seen within 6 months in all patients. The FDA has recently allowed an additional 20 patients to be enrolled...
Nasdaq GlobeNewswire
04/06/2024

Deep integration of proven AI tools into Philips cardiovascular ultrasound…

New FDA-cleared AI-enabled applications include the industry's first automated tool for segmental wall motion scoring of the heart to quickly and objectively identify disorders including coronary artery disease and cardio-oncology issues in secondsFirst fully automated 3D quantification of mitral regurgitation (MR) volumes* designed to provide reproducible, efficient analysis helps clinicians make better-informed decisions for patients with heart valve disease Amsterdam, the...
Nasdaq GlobeNewswire
04/06/2024

Akari Therapeutics Secures $7.6 Million in Upsized Financing Round

BOSTON and LONDON, June04, 2024(GLOBE NEWSWIRE) -- Akari Therapeutics Plc (Nasdaq: AKTX), an innovative biotechnology company advancing therapies for autoimmune and inflammatory diseases, today announced the successful initial closing of a private placement financing round. This transaction is expected to raise an aggregate of approximately $7.6 million in gross proceeds from both new and existing investors. "We are pleased to announce this financing for Akari Therapeutics," said Samir…
Nasdaq GlobeNewswire
04/06/2024

Evolution Optiks Receives U.S. FDA 510(k) Clearance for Breakthrough Eye…

The LFR-260 is a compact, portable, fully digital device that can be operated remotely from anywhere in the world via tablet which makes it ideal for telemedicine. Its integrated micro lens arrays and ultra-high pixel density displays enable it to generate ray-traced, multi-focal optotypes, in real-time, making dedicated refraction rooms, wall charts, and back-and-forth changing of physical lenses a thing of the past. The proprietary QuadView™ technology can show multiple slightly different…
PR Newswire
04/06/2024

Businesses Have One Year to Prepare and Comply with the European Accessibility…

The EAA was enacted April 2019 and requires product manufacturers and service providers active in EU member states to meet the requirements of the legislation by June 28, 2025. The EAA applies to most companies providing certain goods and services in the EU, with a primary focus on the accessibility of digital assets such as websites and mobile applications and excluding microenterprises that provide services only. The EAA was enactedApril 2019and requires product manufacturers and service...
PR Newswire
04/06/2024

Masdar City to Showcase Its Life Sciences Hub at BIO24 in San Diego

Masdar City's involvement at BIO24 aligns with the Government of Abu Dhabi's strategic ambition - 'Abu Dhabi Vision 2030' - which prioritizes the development of the life sciences industry as a key driver of economic diversification. Supported by the UAE government's strategic initiatives, Masdar City is fostering a vibrant ecosystem that promotes scientific research, innovation, and commercialization. Masdar City's involvement at BIO24 aligns with the Government ofAbu Dhabi'sstrategic...
PR Newswire
04/06/2024

Counsellingo.com: A new professional directory of over a thousand self-employed…

Witney was the co-founder of the world's first internet recruitment service, JobServe, back in 1994. In 2000 JobServe was top of the Sunday Times Profit Track 100 league table, and in 2001 JobServe was the first 'dot com' business to receive a Queen's Award for Enterprise. Witney was the co-founder of the world's first internet recruitment service,JobServe, back in 1994. In 2000 JobServe was top of theSunday Times Profit Track 100league table, and in 2001 JobServe was the first 'dot com'...
PR Newswire
04/06/2024

Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses…

Fortrea (Nasdaq: FTRE) a leading global contract research organization (“CRO”), today announced it has completed the divestiture of assets relating to its Enabling Services segment, namely its Endpoint Clinical (“Endpoint”) and Fortrea Patient Access (“FPA”) businesses, to Arsenal Capital Partners (“Arsenal”), a leading private equity firm specializing in building market-leading, technology-rich healthcare and industrial growth companies. Endpoint and FPA provide best-in-class...
Nasdaq GlobeNewswire
04/06/2024

RNAi Therapeutics and Technology Market Worth USD 5.36 Billion by 2031 at 16.6%…

RNA interference (RNAi) is an advanced biological process intrinsic to cells, complexly organizing gene expression through precise sequence-directed silencing. Leveraging this mechanism, RNAi therapeutics have emerged as a pioneering drug class, harnessing genes inherent in RNAi properties to regulate cellular expression systems naturally. Their potential to treat a diverse range of conditions, from metabolic and chronic diseases to cancer, has propelled RNAi therapeutics into the spotlight of…
PR Newswire
04/06/2024

Bioimplants Market to Reach $364.8 Billion, Globally, by 2035 at 8.8% CAGR…

Prime determinants of growth Prime determinants of growth The bioimplants market is expected to grow significantly owing to rise in prevalence of cardiovascular diseases, surge in geriatric population, and high adoption of the orthopedic implants for the treatment of joints and other complications. The exponential rise in the prevalence of cardiovascular diseases (CVDs) has emerged as a significant driver propelling the growth of the bioimplants market. Report coverage & details:...
PR Newswire
04/06/2024

Pioneering Innovation from MolecuLight Earns Best Abstract at SAWC Spring 2024

Dr. Charles Andersen, lead author of the study, expressed his enthusiasm about the recognition received at the Symposium for Advanced Wound Care. He stated, "This award is a testament to the potential impact of our research in advancing wound care practices. By integrating multi-modal fluorescence and thermal imaging technologies, we aim to revolutionize the way healthcare professionals assess and manage wounds." Dr.Charles Andersen, lead author of the study, expressed his enthusiasm…
PR Newswire
04/06/2024

Global Thrombectomy Devices Market to Witness Growth at a CAGR of ~5% by 2030 |…

Key Takeaways from the Thrombectomy Devices Market Report Key Takeaways from the Thrombectomy Devices Market Report To read more about the latest highlights related to the thrombectomy devices market, get a snapshot of the key highlights entailed in theGlobal Thrombectomy Devices Market Report Thrombectomy Devices Overview Thrombectomy devices represent a groundbreaking advancement in the field of interventional medicine, offering a minimally invasive solution for treating...
PR Newswire
04/06/2024

Department of Health - Abu Dhabi Partners with Pfizer to Advance Research in…

Dr Asma Ibrahim Al Mannaei, said: "The collaboration between the DoH and Pfizer represents a significant step towards harnessing real-world data in the region and better understanding patient populations from the vast available data in Abu Dhabi. By partnering with Pfizer on real-world data, we aim to drive advancements in healthcare prediction, prevention, personalised treatment and access, not only benefiting healthcare professionals and patients in Abu Dhabi, but also contributing to the…
PR Newswire
04/06/2024

The COSMETIC 360 international trade show will celebrate 10 years of cosmetics…

Organised by COSMETIC VALLEY, the world's leading fragrance and cosmetics network and coordinator of the French industry for 30 years, this 10 thedition will bring together 250 exhibitors and over 5,000 international decision-makers from 70 countries to discuss the latest innovations in the industry. The theme of longevity and sustainability will be the focus of this anniversary event. And to mark its 10 thedition in this Olympic year, COSMETIC 360 will be organising the...
PR Newswire
04/06/2024

PharmaMar presents encouraging results at ASCO for Small Cell Lung Cancer

Regarding this disease, the results presented by the company at ASCO show that the combination of its drug for this pathology, Zepzelca® (lurbinectedin), in combination with irinotecan produces a synergy that enhances the activity of lurbinectedin, resulting in high and durable response rates in populations that are sensitive, with a chemotherapy-free interval greater than 90 days (CTFI> 90 days), and platinum-resistant with a chemotherapy-free interval of less than 90 days (CTF< 90 days)…
PR Newswire
04/06/2024

ATTEND FDI WORLD DENTAL FEDERATION'S VIRTUAL SUMMIT SHOWCASING SUSTAINABLE…

"We are delighted to bring back the Sustainability in Dentistry Summit this year, reaffirming our dedication to shaping a more sustainable future. Environmental responsibility is critical in dentistry, a commitment we owe to our planet and future generations. We invite all stakeholders to engage in this enlightening three-day event and join us in fostering a healthier, eco-conscious approach to oral healthcare." – Dr Greg Chadwick, FDI President "We are delighted to bring back…
PR Newswire
04/06/2024

Sectra adds IT solution for genomics in cancer diagnostics--first deployment at…

Analysis of genetic information, genomics, is increasingly used in healthcare today to better diagnose and treat patients. Individualized care based on, among other data, genetic information is often referred to as precision medicine and is a rapidly growing field. Analysis of genetic information, genomics, is increasingly used in healthcare today to better diagnose and treat patients. Individualized care based on, among other data, genetic information is often referred to as precision...
PR Newswire
04/06/2024
Altri  Comunicati